| [Cochleovestibular disorders: approaches to diagnostics and treatment]. | |
| | |
MedLine Citation:
|
PMID: 22334927 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The aim of this work was to evaluate the efficacy of introduction of milgamma and milgamma compositum in the treatment of 52 patients with cochleovestibular disorders of different etiology. Thirteen patients enrolled in the study received standard therapy and 39 others were given its combination with milgamma preparations. Combined therapy with milgamma and milgamma compositum ensured faster vestibular compensation including posturographic characteristics than the standard treatment (within 3-4 weeks compared with 5 weeks in controls). The results of the study give reason to recommend milgamma and milgamma compositum as neurotropic medicines in addition to standard therapy for the management of the patients presenting with cochleovestibular disorders for the acceleration of the vestibular compensation. |
| | |
Authors:
|
- |
Publication Detail:
|
Type: English Abstract; Journal Article |
Journal Detail:
|
Title: Vestnik otorinolaringologii Volume: - ISSN: 0042-4668 ISO Abbreviation: Vestn. Otorinolaringol. Publication Date: 2011 |
Date Detail:
|
Created Date: 2012-02-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0416577 Medline TA: Vestn Otorinolaringol Country: Russia (Federation) |
Other Details:
|
Languages: rus Pagination: 55-8 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [The efficacy of the application of essential oils for the prevention of acute respiratory diseases ...
Next Document: [Specific microendoscopic characteristics of intranasal mucosa in patients presenting with chronic r...